Effect of piperonyl butoxide on cell replication and xenobiotic metabolism in the livers of CD-1 mice and F344 rats

Fundamental and Applied Toxicology

Volumn 38, Issue 1, 1997, Pages 64-74

  Phillips, John C ^a   Price, Roger J ^a   Cunninghame, Morag E ^a   Osimitz, Tom G ^b   Cockburn, Andrew ^c   Gabriel, Karl L ^d   Preiss, Fred J ^e   Butler, William H ^a   Lake, Brian G ^a  

^a BIBRA INTERNATIONAL   (United Kingdom)

^b S C Johnson & Son Inc   (United States)

^c AgrEvo UK Limited   (United Kingdom)

^d Biosearch Inc   (United States)

^e McLaughlin Gormley King Co   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENOBARBITAL; PIPERONYL BUTOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIVISION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME INDUCTION; HEPATOMEGALY; HYPERTROPHY; LIVER HYPERPLASIA; LIVER TOXICITY; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; XENOBIOTIC METABOLISM;

ANIMALIA;

EID: 26844479266     PISSN: 02720590     EISSN: None     Source Type: Journal    
DOI: 10.1006/faat.1997.2326     Document Type: Article

References (41)

1. Adams, N. H., Levi, P. E., and Hodgson, E. (1993). Regulation of cytochrome P-450 isozymes by methylenedioxyphenyl compounds. Chem. Biol. Interact. 86, 255-274.
2. Ames, B. N., Shigenaga, M. K., and Gold, L. S. (1993). DNA lesions, inducible DNA repair, and cell division: Three key factors in mutagenesis and carcinogenesis. Environ. Health Perspect. 101(Suppl. 5), 35-44.
3. Andersen, M. E., Mills, J. J., Jirtle, R. L., and Greenlee, W. F. (1995). Negative selection in hepatic tumor promotion in relation to cancer risk assessment. Toxicology 102, 223-237.
4. Barrass, N. C., Price, R. J., Lake, B. G., and Orton, T. C. (1993). Comparison of the acute and mitogenic effects of the peroxisome proliferators methylclofenapate and clofibric acid in rat liver. Carcinogenesis 14, 1451-1456.
5. Beamand, J. A., Price, R. J., Phillips, J. C., Butler, W. H., Glynne Jones, G. D., Osimitz, T. G., Gabriel, K. L., Preiss, F. J., and Lake, B. G. (1996). Lack of effect of piperonyl butoxide on unscheduled DNA synthesis in precision-cut human liver slices. Mutat. Res. 371, 273-282.
6. Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T., and Mayer, R. T. (1985). Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34, 3337-3345.
7. Butler, W. H. (1996). A review of the hepatic tumors related to mixed-function oxidase induction in the mouse. Toxicol. Pathol. 24, 484-494.
8. Butler, W. H., Gabriel, K. L., Preiss, F. J., and Osimitz, T. G. (1996). Lack of genotoxicity of piperonyl butoxide. Mutat. Res. 371, 249-258.
9. Cardy, R. H., Renne, R. A., Warner, J. W., and Cypher, R. L. (1979). Carcinogenesis bioassay of technical-grade piperonyl butoxide in F344 rats. J. Natl. Cancer Inst. 62, 569-578.
10. Cohen, S. M., and Ellwein, L. B. (1990). Cell proliferation in carcinogenesis. Science 249, 1007-1011.
11. Evans, J. G., Collins, M. A., Lake, B. G., and Butler, W. H. (1992). The histology and development of hepatic nodules and carcinoma in C3H/ He and C57BL/6 mice following chronic phenobarbitone administration. Toxicol. Pathol. 20, 585-594.
12. Fennell, T. R., Sweatman, B. C., and Bridges, J. W. (1980). The induction of hepatic cytochrome P-450 in C57 BL/10 and DBA/2 mice by isosafrole and piperonyl butoxide. A comparative study with other inducing agents. Chem,-Biol. Interact. 31, 189-201.
13. Fujitani, T., Ando, H., Fujitani, K., Ikeda, T., Kojima, A., Kubo, Y., Ogata, A., Oishi, S., Takahashi, H., Takahashi, O., and Yoneyama, M. (1992). Sub-acute toxicity of piperonyl butoxide in F344 rats. Toxicology 72, 291-298.
14. Fujitani, T., Tada, Y., and Yoneyama, M. (1993a). Hepatotoxicity of piperonyl butoxide in male F344 rats. Toxicology 84, 171-183.
15. Fujitani, T., Tanaka, T., Hashimoto, Y., and Yoneyama, M. (1993b). Sub-acute toxicity of piperonyl butoxide in ICR mice. Toxicology 83, 93-100.
16. Goldstein, J. A., Hickman, P., and Kimbrough, R. D. (1973). Effects of purified and technical piperonyl butoxide on drug-metabolizing enzymes and ultrastructure of rat liver. Toxicol. Appl. Pharmacol. 26, 444-458.
17. Goldsworthy, T. L., Morgan, K. T., Popp, J. A., and Butterworth, B. E. (1991). Guidelines for measuring chemically induced cell proliferation in specific rodent target organs. In: Chemically Induced Cell Proliferation: Implications for Risk Assessment (B. E. Butterworth, T. D. Slaga, W. Farland and M. McClain, Eds.), pp. 253-284. Wiley-Liss, New York.
18. Graham, C. (1987). Report No. 81690 from. Bio-Research Ltd. Laboratory, Quebec, Canada, submitted to WHO by Piperonyl Butoxide Task Force.
19. Grasso, P., and Hinton, R. H. (1991). Evidence for and possible mechanisms of nongenotoxic carcinogenesis in rodent liver. Chem.-Biol. Interact. 248, 271-290.
20. Grasso, P., Sharratt, M., and Cohen, A. J. (1991). Role of persistent, non-genotoxic tissue damage in rodent cancer and relevance to humans. Annu. Rev. Pharmacol. Toxicol. 31, 253-287.
21. Hermansky, S. J., and, Wagner, C. L. (1993). Chronic Dietary Oncogenicity Study with Piperonyl Butoxide in CD-1 Mice. Bushy Run Research Corp. Project No. 91N0134.
22. Japenga, A. C., Davies, S., Price, R. J., and Lake, B. G. (1993). Effect of treatment with pyrazine and some derivatives on cytochrome P-450 and some enzyme activities in rat liver. Xenobiotica 23, 169-179.
23. Jirtle, R. L. (1994). Liver tumor promotion and breast cancer chemoprevention: common mechanisms. In Nongenotoxic Carcinogenesis. Ernst Schering Research Foundation Workshop 10 (A. Cockburn and L. Smith, Eds.), pp. 157-171. Springer-Verlag, Berlin.
24. Kawachi, T., Komatsu, T., Kada, T., Ishidate, M., Sasaki, M., Sugiyama, T., and Tazima, Y. (1980). Results of recent studies on the relevance of various short-term screening tests in Japan. Appl. Methods Oncol. 3, 253-276.
25. Lake, B. G. (1987). Preparation and characterisation of microsomal fractions for studies on xenobiotic metabolism. In Biochemical Toxicology: A Practical Approach. (K. Snell and B. Mullock, Eds.), pp.183-215. IRL Press, Oxford.
26. Lake, B. G., Hopkins, R., Chakraborty, J., Bridges, J. W., and Parke, D. V. (1973). The influence of some hepatic enzyme inducers and inhibitors on extrahepatic drug metabolism. Drug Metab. Dispos. 1, 342-349.
27. Loury, D. J., Goldsworthy, T. L., and Butterworth, B. E. (1987). The value of measuring cell replication as a predictive index of tissue-specific tumorigenic potential. In Nongenotoxic Mechanisms in Carcinogenesis (B. E. Butterworth and T. J. Slaga, Eds.) pp. 119-136. Cold Spring Harbor Laboratories, Cold Spring Harbor, NY. [Banbury Report 25].
28. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
29. Maekawa, A., Onodera, H., Furuta, K., Tanigawa, H., Ogiu, T., and Hayashi, Y. (1985). Lack of evidence of carcinogenicity of technical-grade piperonyl butoxide in F344 rats: Selective induction of ileocaecal ulcers. Food Chem. Toxicol. 23, 675-682.
30. NCI (1979). Bioassay of Piperonyl Butoxide for Possible Carcinogenicity. U.S. Department of Health, Education and Welfare, DHEW Publication No. (NIH) 79-1375.
31. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C., and Nebert, D. W. (1996). P450 superfamily: Update on new sequences, accession numbers and nomenclature. Pharmacogenetics 6, 1-42.
32. Okey, A. B. (1990). Enzyme induction in the cytochrome P-450 system. Pharmacol. Ther. 45, 241-298.
33. Omura, T., and Sato, R. (1964). The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
34. Rosenkranz, H. S., Ennever, F. K., and Klopman, G. (1990). Relationship between carcinogenicity in rodents and the induction of sister chromatid exchanges and chromosomal aberrations in Chinese hamster ovary cells. Mutagenesis 5, 559-571.
35. Sarles, M. P., and Vandegrift, W. B. (1952). Chronic oral toxicity and related studies on animals with the insectide and pyrethrum synergist, piperonyl butoxide. Am. J. Trop. Med. Hyg. 1, 862-883.
36. Smith, D. A. (1991). Species differences in metabolism and pharmacokinetics: Are we close to an understanding? Drug Metab. Rev. 23, 355-373.
37. Takahashi, O., Oishi, S., Fujitani, T., Tanaka, T., and Yoneyama, M. (1994a). Piperonyl butoxide induces hepatocellular carcinoma in male CD-1 mice. Arch. Toxicol. 68, 467-469.
38. Takahashi, O., Oishi, S., Fujitani, T., Tanaka, T., and Yoneyama, M. (1994b). Chronic toxicity studies of piperonyl butoxide in F344 rats : Induction of hepatocellular carcinoma. Fund. Appl. Toxicol. 22, 293-303.
39. Wagstaff, D. J., and Short, C. R. (1971). Induction of hepatic microsomal hydroxylating enzymes by technical piperonyl butoxide and some of its analogues. Toxicol. Appl. Pharmacol. 19, 54-61.
40. White, T. J., Goodman, D., Shulgin, A. T., Castagnoli, N. Jr., Lee, R., and Petrakis, N. L. (1977). Mutagenic activity of some centrally active aromatic amines in Salmonella typhimurium. Mutat. Res. 56, 199-202.
41. Wilson, D. M., Goldsworthy, T. L., Popp, J. A., and Butterworth, B. E. (1992). Evaluation of genotoxicity, pathological lesions, and cell proliferation in livers of rats and mice treated with furan. Environ. Mol. Mutagen. 19, 209-222.